Oligometastatic non-small cell lung cancer: is there a role for locoregional therapy?
作者信息
Berzenji Lawek, Van Schil Paul E
机构信息
Department of Thoracic and Vascular Surgery, Antwerp University Hospital, Edegem (Antwerp), Belgium.
出版信息
J Thorac Dis. 2017 Jul;9(7):1814-1817. doi: 10.21037/jtd.2017.06.108.
Abstract
摘要
相似文献
1
Oligometastatic non-small cell lung cancer: is there a role for locoregional therapy?寡转移非小细胞肺癌：局部区域治疗有作用吗？
J Thorac Dis. 2017 Jul;9(7):1814-1817. doi: 10.21037/jtd.2017.06.108.
2
Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.根治性治疗的同步与异时寡转移非小细胞肺癌的长期预后
BMC Cancer. 2016 Jun 2;16:348. doi: 10.1186/s12885-016-2379-x.
3
Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic Stage IV non-small cell lung cancer?: Secondary analysis of two prospective studies.化疗联合放射治疗能否提高非寡转移IV期非小细胞肺癌患者的总生存率？两项前瞻性研究的二次分析
BMC Cancer. 2016 Nov 21;16(1):908. doi: 10.1186/s12885-016-2952-3.
4
Radical treatment of oligometastatic non-small cell lung cancer: Ready for prime time?寡转移非小细胞肺癌的根治性治疗：时机已到？
Eur J Cancer. 2017 Jul;79:149-151. doi: 10.1016/j.ejca.2017.04.008. Epub 2017 May 8.
5
Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.寡转移非小细胞肺癌的消融治疗。
Clin Lung Cancer. 2017 Nov;18(6):595-606. doi: 10.1016/j.cllc.2017.03.002. Epub 2017 Mar 14.
6
Local treatment of oligometastatic recurrence in patients with resected non-small cell lung cancer.局部治疗切除后非小细胞肺癌寡转移复发。
Lung Cancer. 2013 Dec;82(3):431-5. doi: 10.1016/j.lungcan.2013.08.006. Epub 2013 Sep 19.
7
8
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).一项关于寡转移前列腺癌观察与立体定向消融放疗对比的II期随机试验（ORIOLE）。
BMC Cancer. 2017 Jun 29;17(1):453. doi: 10.1186/s12885-017-3455-6.
9
Changing equipoise in the landscape of radiation for oligometastatic lung cancer.寡转移性肺癌放疗格局中的平衡变化
Transl Lung Cancer Res. 2019 Sep;8(Suppl 2):S184-S191. doi: 10.21037/tlcr.2019.07.09.
10
Risk factors and management of oligometastatic non-small cell lung cancer.寡转移非小细胞肺癌的危险因素与管理
Ther Adv Respir Dis. 2016 Aug;10(4):338-48. doi: 10.1177/1753465816642636. Epub 2016 Apr 8.
引用本文的文献
1
Clinical prognostic factors in surgically treated oligometastatic non-small cell lung cancer: a systematic review.手术治疗寡转移非小细胞肺癌的临床预后因素：一项系统评价
Transl Lung Cancer Res. 2021 Jul;10(7):3401-3408. doi: 10.21037/tlcr-20-1123.
2
Surgical approaches in patients with oligometastatic non-small cell lung cancer.寡转移非小细胞肺癌患者的手术治疗方法
J Thorac Dis. 2018 Jan;10(1):498-502. doi: 10.21037/jtd.2017.11.135.
本文引用的文献
1
Salvage Operation in Case of Oligometastatic Disease.
Ann Thorac Surg. 2017 May;103(5):e409-e411. doi: 10.1016/j.athoracsur.2016.11.019.
2
Local consolidative therapy may be beneficial in patients with oligometastatic non-small cell lung cancer.局部巩固治疗可能对寡转移非小细胞肺癌患者有益。
CA Cancer J Clin. 2017 Mar;67(2):89-90. doi: 10.3322/caac.21363. Epub 2017 Jan 17.
3
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.一线全身治疗后无进展的寡转移性非小细胞肺癌患者的局部巩固治疗与维持治疗或观察比较：一项多中心、随机、对照、2期研究
Lancet Oncol. 2016 Dec;17(12):1672-1682. doi: 10.1016/S1470-2045(16)30532-0. Epub 2016 Oct 24.
4
Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT).寡转移定向立体定向体部放疗（SBRT）后长期生存的临床和分子标志物。
Cancer. 2016 Jul 15;122(14):2242-50. doi: 10.1002/cncr.30058. Epub 2016 May 20.
5
The IASLC Lung Cancer Staging Project: Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer.IASLC 肺癌分期项目：对即将发布的第八版 TNM 肺癌分类中 M 描述符修订的建议。
J Thorac Oncol. 2015 Nov;10(11):1515-22. doi: 10.1097/JTO.0000000000000673.
6
Phase II multicenter clinical trial of pulmonary metastasectomy and isolated lung perfusion with melphalan in patients with resectable lung metastases.肺转移瘤切除术和肺隔离灌注丝裂霉素治疗可切除肺转移瘤的 II 期多中心临床试验。
J Thorac Oncol. 2014 Oct;9(10):1547-53. doi: 10.1097/JTO.0000000000000279.
7
MicroRNA expression characterizes oligometastasis(es).微小 RNA 的表达特征可确定寡转移灶。
PLoS One. 2011;6(12):e28650. doi: 10.1371/journal.pone.0028650. Epub 2011 Dec 13.
8
Surgical treatment of oligometastatic non-small cell lung cancer.寡转移非小细胞肺癌的外科治疗。
Lung Cancer. 2010 Sep;69(3):251-8. doi: 10.1016/j.lungcan.2010.05.003.
9
Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions.立体定向脑部和/或全身放疗治疗寡转移病变患者的临床结果。
Jpn J Clin Oncol. 2010 Aug;40(8):788-94. doi: 10.1093/jjco/hyq044. Epub 2010 Apr 20.
10
Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis.转移性肺癌一线全身治疗后巩固性立体定向体部放射治疗是否有作用？失败模式分析。
Acta Oncol. 2009;48(4):578-83. doi: 10.1080/02841860802662722.
Zotero 插件